Find Academic Supervisors

Bodil HolstView profile

Professor

• Surface Science
• Scientific Instrumentation
• 2D Materials
• +3 more

Bodil Holst is a Professor at the University of Bergen's Department of Physics and Technology , specializing in surface science and scientific instrumentation development . Her research spans 2D materials , helium atom scattering , and archaeometry applications. She leads projects like Nanometer-Resolution Matter-Wave Lithography (FET-Open), 2D Material Properties (NFR FRIPRO), and Wind Turbine Erosion Prevention (Equinor). Her Nanophysics Group has produced groundbreaking work on graphene's temperature-dependent rigidity and icephobic surfaces . First neutral helium microscope images (2008) Recorded bending rigidity of 2D materials (2018-2021) Developed solid-state conversion techniques for sapphire (2017-2021) Her teaching innovations in classical mechanics explore retrieval practice and digital learning structure , documented in Physics Education and Physical Review Physics Education Research .

Monika RojewskaView profile

Assistant Professor

• Biophysical Chemistry
• Membrane Science
• Drug Delivery Systems
• +3 more

Dr. Monika Rojewska is a faculty member at the Institute of Chemical Technology and Engineering, Department of Chemical Technology, at Poznan University of Technology. She earned her PhD in Chemical Technology from the same institution in 2012 and has been actively contributing to research in membrane science and biomaterials. Her primary research interests focus on the biophysical analysis of model biological membranes, with special emphasis on interactions between membrane components and various compounds including drugs, biosurfactants, nanoparticles, and mucoadhesive polymers. She specializes in Langmuir monolayer techniques and has extensive experience with membrane preparation and characterization. Dr. Rojewska's publication record demonstrates a consistent research trajectory in membrane science and drug delivery systems over the past decade. Her recent work (2022-2025) has increasingly focused on the interactions between natural compounds like saponins and bacterial membranes, with implications for antibiotic enhancement and novel drug delivery approaches. She has published in high-impact journals across biophysics, materials science, and pharmaceutical research. As an academic, Dr. Rojewska teaches courses in Chemical Technology, including Fundamentals of Chemical Technology, Technology of Monomers, and Membrane Separation Techniques. She also serves as an Associate Editor for the journal "Membranes" and has participated in the "Integrated university for the future" project. She has supervised doctoral research, most notably guiding Aleksandra Bartkowiak's dissertation on mucoadhesive polymers and their mixtures as components of drug carriers. Her collaborative work extends to the Department of Drug Form Technology at Poznan University of Medical Sciences since 2011.

• Nanotechnology
• Materials Science
• Drug Delivery
• +3 more

Wali Inam is a Researcher at the Faculty of Natural Sciences and Technology of Åbo Akademi University. Their work focuses on Pharmacy Solutions for health , with a strong emphasis on Nanotechnology , Materials Science , and Drug Delivery . They have contributed to the understanding of nanoparticle behavior and characterization techniques. Current Affiliation : Åbo Akademi University, Faculty of Natural Sciences and Technology Contact : wali.inam@abo.fi Research interests include: Nanoparticle Characterization (Dynamic Light Scattering, Transmission Electron Microscopy) Microfluidics for nanoprecipitation and encapsulation processes Stability Evaluation of nanoformulated proteins Electrokinetic Properties of polymeric nanoparticles Molecular Dynamics simulations in nanoscale assembly Buffer Compatibility in nanoparticle systems Recent publications highlight their work in Nanostructured Materials (100% relevance), Particle Characterization (93% relevance), and Flow Dynamics (100% relevance). Their contributions align with Sustainable Development Goals related to health and well-being.

• Pharmacology
• Molecular Biophysics
• Biochemistry
• +8 more

Karen S. Anderson is a Professor of Pharmacology and Molecular Biophysics and Biochemistry at Yale School of Medicine, with a primary appointment in the Department of Pharmacology. She serves as Co-Leader of Developmental Therapeutics at Yale Cancer Center and Co-Director of the Therapeutics/Chemotherapy Program. Dr. Anderson is also an undergraduate research mentor and fellow at Pierson College at Yale, where she advises freshman students. Dr. Anderson's research program focuses on mechanistic enzymology and structure-based drug design to develop novel therapeutics. Her work centers on understanding molecular mechanisms of enzymes that play critical roles in cancer and infectious diseases, including HIV/AIDS. She has made significant contributions to the understanding of HIV reverse transcriptase, anticancer targets like EGFR and HER-2, and enzymes involved in parasitic infections. Her laboratory employs a multidisciplinary approach combining biophysical techniques, structural studies, and computational methods to advance drug discovery. Analysis of her recent publications (2023-2025) reveals a strong research trajectory spanning three main areas: HIV drug resistance and novel inhibitors, cancer therapeutics focusing on resistance mechanisms and targeted therapies, and antiviral/antimicrobial drug development including work on SARS-CoV-2. Her research demonstrates consistent innovation in structure-based drug design approaches across multiple disease areas. Selected Awards and Honors: Enzymes, Coenzymes, & Metabolic Pathways Gordon Research Conference Chair (2001) Yale Cancer Breast Cancer Initiative Research Award (1996) Dean's Young Faculty Award from Yale University (1991) Multiple Monsanto Research Achievement Awards (1985-1989) YWCA Women's Leadership Award (1986-1987) Dr. Anderson has trained over 50 undergraduates, graduate students, M.D./Ph.D. students and postdoctoral fellows who have gone on to successful careers in academia and industry. Her laboratory, the Anderson Lab, focuses on translating mechanistic and structural studies into novel therapeutic approaches for viral infections and cancer. The lab utilizes a range of biophysical techniques to study clinically relevant proteins with the goal of developing more effective therapies for conditions including cancer, infectious diseases, and neurodegenerative disorders.

Dustin HuardView profile

Research Fellow

• Structural Biology
• Protein Biochemistry
• Protein Aggregation
• +3 more

Dustin Huard is a Postdoctoral Fellow at the Georgia Institute of Technology, conducting research within the Lieberman Research Group. His work bridges structural biology, protein biochemistry, and environmental science, with primary affiliations in chemistry-focused research despite the absence of explicit departmental or school designation in source materials. His research portfolio centers on two interconnected domains: Structural characterization of myocilin and its role in glaucoma pathogenesis, particularly focusing on olfactomedin domain aggregation Mechanistic studies of bacterial proteins interacting with methane clathrates and biodegradable plastics in extreme environments Employing advanced techniques including cryo-TEM, X-ray crystallography, and computational modeling, his work addresses fundamental questions in protein misfolding diseases and environmental biotechnology. Analysis of Dr. Huard's publication trajectory (2019-2025) reveals sophisticated integration of structural biology with environmental applications. His glaucoma research demonstrates progression from basic myocilin structural characterization to AI-driven pathogenicity prediction frameworks, while his clathrate work establishes novel paradigms for understanding microbial interactions with gas hydrates. Both domains showcase consistent methodological rigor combining experimental structural analysis with biophysical characterization. As an integral member of the Lieberman Research Group, Dr. Huard contributes to a collaborative environment focused on protein structure-function relationships with translational implications for human health and environmental sustainability. His research program demonstrates strong potential for advancing therapeutic strategies for glaucoma and developing biotechnological solutions for plastic waste management and energy resource challenges.

Tom WildView profile

Lecturer

• Nature-based solutions (NBS)
• Urban water management
• River restoration and daylighting
• +7 more

Tom Wild is a Lecturer at the School of Architecture and Landscape , University of Sheffield, specializing in nature-based solutions (NBS) for urban sustainability. His work bridges ecology, environmental planning, and socio-economic policy to address climate change adaptation, river restoration, and equitable green infrastructure investments. Focuses on biophysical and socio-political conditions enabling ecosystem rehabilitation Principal Investigator for Horizon 2020 CONEXUS project (€5M, 30+ partners) Active in economic valuation of blue-green infrastructure and governance frameworks Coordinates ESRC-funded Planning for Nature and NERC-funded GP4Streets projects His research spans urban ecology , river daylighting , and green space equity , with extensive publications on NBS implementation across Europe and Latin America. Current work examines climate adaptation strategies through the lens of community engagement and policy innovation. Key research trends include: Integration of NBS in urban drainage systems Transdisciplinary governance models Cultural and economic barriers to adoption Long-term viability of green infrastructure Professional engagements include Chartered Biologist status (Society of Biology) and prior leadership roles in environmental agencies, reflecting his commitment to translating research into practice through community partnerships and policy advocacy.

Sabrina Santos OliveiraView profile

Associate Professor

• Molecular Targeted Therapies
• Photodynamic Therapy
• Nanobodies
• +4 more

Sabrina Santos Oliveira is an Associate Professor with a shared position between the Cell Biology, Neurobiology and Biophysics division of the Department of Biology and the Pharmaceutics division of the Department of Pharmaceutical Sciences at Utrecht University's Faculty of Science. Her research focuses on Molecular Targeted Therapies, particularly using nanobodies to enhance the selectivity of photodynamic therapy for cancer treatment. Dr. Oliveira received her initial introduction to Utrecht University through an internship at the Department of Pharmaceutical Sciences in 2004 during her studies at the Faculty of Pharmacy of Coimbra University in Portugal. After graduation, she obtained an individual doctoral grant from the Portuguese Foundation for Science and Technology (FCT) to complete her PhD research on Targeted Cancer Therapies (2004-2008). She then worked as a postdoc on nanobody-based tracers for optical molecular imaging (2008-2012). In 2012, she was awarded a VENI grant from the Netherlands Organisation for Research (NWO-STW), which allowed her to start her own research line focused on rendering photodynamic therapy more selective to cancer cells using nanobodies. In 2016, she received a Starting Grant from the European Research Council (ERC) to continue her research. She was appointed Assistant Professor in July 2016 and Associate Professor in May 2019. Dr. Oliveira's research group focuses on developing and evaluating improved therapies directed at relevant molecular targets. Her work primarily centers on nanobody-targeted photodynamic therapy, which uses the small size and binding specificity of nanobodies to target photosensitizers specifically to cancer cells. This approach aims to improve the selectivity of photodynamic therapy, which is currently limited by the non-specific interaction of hydrophobic photosensitizers with all cell types. Her ERC-funded KILLCANCER project (Starting Grant #677582) has investigated the mechanism of nanobody-targeted PDT and evaluated this approach in larger animals, with the goal of translating findings to human patients. The research has potential applications in treating various cancers, including feline oral carcinoma, which is being studied in collaboration with the University Clinic for Companion Animal Health. Analysis of Dr. Oliveira's recent publications reveals a strong focus on translating nanobody technology from basic research to clinical applications. Her work spans multiple therapeutic areas including cancer treatment, viral infection therapies, and advanced drug delivery systems. The research demonstrates significant translational potential, with applications in both human and veterinary medicine, particularly in improving cancer treatment options through more selective targeting approaches. VENI grant from Netherlands Organisation for Research (NWO-STW) (2012) Starting Grant from European Research Council (ERC) (2016) Individual doctoral grant from Portuguese Foundation for Science and Technology (FCT) Dr. Oliveira's laboratory includes a technician, multiple postdocs, and PhD students working on various aspects of nanobody-targeted therapies. Her research has been highlighted by the Morris Animal Foundation as a promising new treatment for cats suffering from oral squamous cell carcinoma, demonstrating the translational potential of her work from bench to bedside (and clinic). The collaborative nature of her research is evident in the numerous collaborations with other departments and institutions, including the University Medical Center Utrecht and veterinary clinics.

Karl S. BookshView profile

Professor

• Chemometrics
• Analytical Spectroscopy
• Environmental Monitoring
• +4 more

Karl S. Booksh is a Professor in the Department of Chemistry and Biochemistry at the University of Delaware's College of Arts & Sciences. His research integrates chemometrics with analytical spectroscopy to develop advanced chemical sensors for environmental, biomedical, and industrial applications. Education B.S., 1990, University of Alaska - Fairbanks Ph.D., 1994, University of Washington - Seattle Research interests focus on: Combining instrumental design with chemometric methods for enhanced sensor performance Development of fiber optic sensors (SPR, Raman, fluorescence) Machine learning applications in environmental monitoring (hydrothermal vents, soil analysis) Biomedical diagnostics (protein/cytokine detection, male infertility assays) Food chemistry (edible oil authentication, peroxide value prediction) Recent publications demonstrate expertise in: Portable spectroscopic systems (LIBS, DART TOFMS) Environmental and forensic chemical analysis Advanced data analysis for classification and detection Cultural heritage science (textile/pigment analysis) Industrial process monitoring and soft sensing His lab actively engages in educational outreach through: NSF-funded REU program for students with disabilities ACS Project SEED for economically disadvantaged high school students Hands-on research training in chemometrics and spectroscopy

Xiaowei WangView profile

Professor

• Molecular Imaging
• Nanotherapeutics
• Cardiovascular Disease
• +3 more

Professor Xiaowei Wang is a leading academic at the Baker Heart and Diabetes Institute , where she heads the Molecular Imaging and Nanotherapeutics laboratory and co-leads the Heart Attack Program and Centre for Cardiometabolic mRNA Therapy . She holds adjunct and honorary academic appointments at the University of Melbourne, La Trobe University, Monash University, Swinburne University, and Torrens University. Professor Wang earned her PhD from Monash University and is a Fellow of the Australian Academy of Health Sciences (FAHA), Cardiac Society of Australia and New Zealand (FCSANZ), and European Society of Cardiology (FESC). Her research integrates physics, chemistry, biology, and biotechnology to develop clinical-ready diagnostic and therapeutic solutions for cardiovascular disease. Her work focuses on preclinical molecular imaging using advanced technologies like MRI, PET, and photoacoustic imaging to enable early diagnosis and real-time monitoring of treatments. She pioneers mRNA therapeutics and vaccines delivered via micro- and nano-particles to prevent heart attacks, strokes, and inflammation with minimal side effects. Key trends in her publications highlight targeted drug delivery , thrombosis prevention , Nanotherapeutics , and translational cardiovascular research . Her studies often explore the intersection of molecular imaging , biomedical engineering , and clinical applications . Scientific awards and recognitions: National Heart Foundation Future Leader Fellowship Level 2 Baker Institute Sir Laurence Muir Prize World Molecular Imaging Society Mid Career Award Inaugural Fellow of the Australian Society of Molecular Imaging National Heart Foundation Paul Korner Innovation Award Inaugural Women of Colour in STEM Award AVBS Achievement and Career Development Award 40 Under 40 Most Influential Asian-Australian Award Finalist Professor Wang is also deeply committed to equity and mentorship, chairing the Baker Institute’s Mentoring Committee and serving on leadership teams for the Women in Molecular Imaging Network and the Gender Equity and Diversity Committee. She has received over 27 national and international travel grants, 18 research prizes, and 14 Young Investigator Awards, underscoring her impact in the field.

Sean PalecekView profile

Professor

• Biomedical Engineering
• Stem Cell Research
• Tissue Engineering
• +4 more

Sean Palecek is the Milton J. and A. Maude Shoemaker Professor in the Department of Chemical and Biological Engineering at the University of Wisconsin–Madison. His research focuses on engineering platforms to regulate human pluripotent stem cell (hPSC) differentiation for cardiovascular and neurovascular applications. He is based in 3637 Engineering Hall and leads the Palecek Lab, which develops innovative methods for stem cell fate specification and tissue engineering. BChE, Chemical Engineering, University of Delaware MS, Chemical Engineering, University of Illinois at Urbana-Champaign PhD, Chemical Engineering, Massachusetts Institute of Technology Postdoc., Molecular Genetics and Cell Biology, University of Chicago His research integrates stem cell biology with biomaterials and engineering principles to generate functional cardiomyocytes, brain endothelial cells, and mural cells. His lab leverages Notch3 signaling, proteomics, and organoid systems to model diseases and develop regenerative therapies. Current projects emphasize hypoimmunogenic cardiac organoids, vascular grafts, and blood-brain barrier models for neurotherapeutic screening. The 15 most recent articles highlight his work in human pluripotent stem cell (hPSC) differentiation to cardiomyocytes, endothelial cells, and brain mural cells. Key trends include organoid manufacturing , neurovascular unit modeling , metabolic profiling , and biomaterials for cell transport . His team explores Notch3 activation, SNRK signaling, and transcriptional analysis to optimize cell therapy and disease models. Scientific contributions include the Milton J. and A. Maude Shoemaker Professorship, a named chair recognizing his leadership in chemical and biological engineering. For more details, visit his lab’s website: Palecek Lab .

David T. LodowskiView profile

Assistant Professor

• Structural Biology
• G Protein-Coupled Receptors (GPCRs)
• X-ray Crystallography
• +5 more

David T. Lodowski is an active Assistant Professor at Case Western Reserve University School of Medicine holding multiple appointments across the Department of Nutrition, Center for Proteomics and Bioinformatics, and Department of Pharmacology. He also serves as Director of the Biomedical Sciences Training Program. His laboratory focuses on elucidating the structural mechanisms of G protein-coupled receptors (GPCRs) and related signaling pathways using advanced structural biology techniques. Dr. Lodowski completed his BS in cellular and molecular biology from Tulane University in 1998, followed by a PhD in Biochemistry from the University of Texas at Austin in 2005. He then completed a postdoctoral fellowship in the Palczewski Laboratory at Case Western Reserve University from 2005-2011, where he examined structural changes in bovine rhodopsin during photoactivation and GPCR activation. His research primarily centers on GPCR signaling dynamics, utilizing X-ray crystallography, electron microscopy, and structural mass spectrometry to study macromolecular complexes. Additional research projects include developing biosensors for markers of hypoxia and fatigue, and investigating aquaporins as membrane gas channels. Dr. Lodowski teaches SYBB 501 Systems Biology & Bioinformatics Journal Club and CBIO 455 Molecular Biology I courses. Analysis of his recent publications shows a strong focus on structural biology of membrane proteins, particularly GPCRs and ion channels, with increasing emphasis on protein footprinting techniques and biosensor development. His work bridges structural biology with physiological applications, demonstrating translational potential in understanding cellular signaling pathways. Awards and Honors: Mt. Sinai Scholar (2012) Current Funding: Biosis AFRL as associate project lead since July 15, 2020. Dr. Lodowski has mentored students through the Biomedical Sciences Training Program which he directs. His laboratory has determined numerous protein structures (including IDs 5HI9, 4X1H, 4YEU, and others) related to GPCR signaling pathways. His research team employs a multidisciplinary approach combining structural biology, biophysics, and biochemistry to investigate the molecular mechanisms underlying GPCR activation and signaling, with implications for understanding numerous physiological processes and developing targeted therapeutics.

Haim H. BauView profile

Professor

• Microfluidics
• Biomedical Engineering
• Applied Physics
• +3 more

Haim H. Bau is the Richard H. & S. L. Gabel Professor of Mechanical Engineering at the University of Pennsylvania. His research bridges mechanical engineering, biomedical applications, and nanotechnology, focusing on microfluidics and molecular detection technologies. Key affiliations: School of Engineering and Applied Science, Department of Mechanical Engineering and Applied Mechanics Research Highlights: Active Control of Flow Patterns Carbon Nanopipettes for Cellular Probes Electrokinetics and Dielectrophoresis In Situ Electron Microscopy (Nanoaquarium) Magneto-Hydrodynamics (MHD) Lab-on-a-Chip for Point-of-Care Diagnostics Scientific Awards: Richard H. & S. L. Gabel Professorship Article Trends: Recent work emphasizes portable microfluidic diagnostics (e.g., SARS-CoV-2, HIV, Zika), CRISPR-enhanced mutation detection, and biophysical studies of microswimmers like C. elegans. Keywords include Molecular Diagnostics, Microfluidics, and Nanotechnology.

Andrew CareView profile

Senior Lecturer

• Nanomedicine
• Synthetic Biology
• Drug Delivery Systems
• +3 more

Andrew Care is a Senior Lecturer and Academic Director of the Biologics Innovation Facility (BIF) at the University of Technology Sydney (UTS), within the School of Life Sciences. He holds a PhD in Chemistry and Biomolecular Sciences from Macquarie University and has held prestigious fellowships, including the Cancer Institute NSW Early Career Fellowship and UTS Chancellor's Research Fellowship. His research focuses on combining synthetic biology and nanomedicine to engineer biologically-derived nanoparticles for drug delivery and vaccines. He is actively involved in industry collaborations, notably as a Chief Investigator in the ARC ITRC IDEAL Hub. Teaching and leadership roles include Program Director for the Biomedical Engineering program and coordination of the Australasian Synthetic Biology Challenge, which fosters student innovation. He has been recognized with a UTS Vice-Chancellor’s Teaching Citation and multiple Dean’s Awards for integrating Work Integrated Learning (WIL) and enhancing student engagement. His contributions to education and research excellence have earned awards for collaboration and partnership. Research interests span nanoparticle engineering, neurodegenerative disease therapies, and biomanufacturing. Notable projects include developing an Alzheimer’s vaccine using encapsulin protein cages and investigating nanoparticle interactions in brain cells. His work bridges academia and industry, emphasizing translational applications in healthcare. Awards: UTS Vice-Chancellor’s Research Excellence Award (2024), UTS Teaching Citation (2024), Multiple Dean’s Awards for Science Initiative, Innovation, and Student Experience. Leadership: Academic Lead of BIF, Editor of SYNTHESIS Magazine, and EMCR Representative in research committees. Grants: Providence Foundation Project Grant (2023), ARC IDEAL Hub funding. Andrew’s labs, including the Biologics Innovation Facility, provide advanced training in biomanufacturing and nanomedicine, equipping students and professionals for industry roles. His research aims to address unmet clinical needs through innovative biomedical solutions.

Wei-Chung Allen LeeView profile

Associate Professor

• Neuroscience
• Connectomics
• Neural Circuits
• +3 more

Wei-Chung Allen Lee, PhD, is an Associate Professor of Neurology and Neurobiology at Harvard Medical School. His research focuses on understanding how neural circuits enable behavior through functional connectomics, combining advanced imaging, machine learning, and computational modeling. The Lee Lab develops tools like X-ray holographic nanotomography and GridTape for high-resolution neural structure analysis. Key interests include circuit principles in Drosophila, cerebellar interneurons, and synaptic wiring in decision-making regions. His work explores structural-functional relationships in networks, conservation across species, and developmental constraints on neural architecture. Recent studies highlight connectomic reconstructions in Drosophila, cerebellar disinhibition mechanisms, and blood-brain barrier heterogeneity. Methodological innovations in microscopy and image restoration underscore his lab’s interdisciplinary approach. The Lee Lab is located at 220 Longwood Avenue, Boston, MA, and collaborates on large-scale neuroimaging pipelines like the Open Connectome Project.

Michael VermeuelView profile

Assistant Professor

• Atmospheric Chemistry
• Air Quality
• Climate Science
• +3 more

Dr. Michael Vermeuel is an Assistant Professor in the Department of Earth, Atmospheric, and Planetary Sciences at Purdue University. He leads the AIR CheM (Atmospheric Interdisciplinary Research in Chemistry and Meteorology) group, focusing on reactive atmospheric gases impacting air quality, climate, and ecosystems. His work combines field observations, chemical transport modeling, and laboratory studies. Education: PhD in Chemistry (2021), University of Wisconsin – Madison MS in Chemistry (2017), University of Wisconsin – Madison BS in Chemistry (2015), The College of New Jersey Research Interests: Dr. Vermeuel’s group investigates the sources and fates of atmospheric chemicals using advanced techniques such as chemical ionization mass spectrometry and micrometeorological flux measurements. Key areas include ozone deposition dynamics, VOC cycling in forests, and marine-abiotic VOC sources. His work bridges laboratory experiments, field campaigns (e.g., FROG-NY, FluCS), and model development to address environmental challenges. Awards: AGU James R. Holton Award (2024) His lab emphasizes interdisciplinary collaboration, with projects addressing urban pollution, wildfire impacts, and climate feedbacks. Current research includes the Fluxes of Reactive Organic Gases in New York (FROG-NY) and the Flux Closure Study (FluCS) at Manitou Experimental Forest.